title: Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome.
abstract: Heart failure has not been described in the setting of TB-immune reconstitution inflammatory syndrome (IRIS). We describe a case of cardiogenic shock in the setting of TB-IRIS four weeks after commencement of antiretroviral therapy. Possible aetiologies and pathophysiology as well as suggested diagnostic and therapeutic approaches to this problem are discussed.
authors.affiliation: Department of Medicine, GF Jooste Hospital, Cape Town, South Africa. chriskenyon0@gmail.com
authors.forename: Chris
authors.initials: C
authors.lastname: Kenyon
authors.forename: Neshaad
authors.initials: N
authors.lastname: Schrueder
authors.forename: Mpiko
authors.initials: M
authors.lastname: Ntsekhe
authors.forename: Graeme
authors.initials: G
authors.lastname: Meintjes
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D004452:Echocardiography; D006678:HIV; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications*; D008279:Magnetic Resonance Imaging; D008297:Male; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D012770:Shock, Cardiogenic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology
chemical_list: D044966:Anti-Retroviral Agents